secwatch.observer — SEC 8-K summary
======================================

Issuer:     Launch One Acquisition Corp. (LPAA)
CIK:        0002015502
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001213900-25-057488
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Launch One Acquisition Corp. to combine with Minovia Therapeutics at $180M valuation, targeting Q4 2025 close
--------------------------------------------------------------------------------

- Minovia pre-money valuation of $180M; equity holders eligible for up to $57.5M earnout based on milestones.
- Launch One trust holds ~$239.7M cash; at least $18M in PIPE investments and $5M bridge financing expected.
- Lead product MNV-201 has FDA Fast Track and Rare Pediatric Disease designations; pivotal trial in preparation.
- Transaction unanimously approved by both boards; expected to close Q4 2025 subject to shareholder approvals.
- Combined company to be named Mito US One Ltd. and list on Nasdaq under new ticker.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2015502/000121390025057488/0001213900-25-057488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2015502/000121390025057488/ea0246872-8k425_launch.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-057488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer